Current views on genetics and epigenetics of cholesterol gallstone disease

Agostino Di Ciaula, David Q.H. Wang, Leonilde Bonfrate, Piero Portincasa

Research output: Contribution to journalReview article

30 Citations (Scopus)

Abstract

Cholesterol gallstone disease, one of the commonest digestive diseases in western countries, is induced by an imbalance in cholesterol metabolism, which involves intestinal absorption, hepatic biosynthesis, and biliary output of cholesterol, and its conversion to bile acids. Several components of the metabolic syndrome (e.g., obesity, type 2 diabetes, dyslipidemia, and hyperinsulinemia) are also well-known risk factors for gallstones, suggesting the existence of interplay between common pathophysiological pathways influenced by insulin resistance, genetic, epigenetic, and environmental factors. Cholesterol gallstones may be enhanced, at least in part, by the abnormal expression of a set of the genes that affect cholesterol homeostasis and lead to insulin resistance. Additionally, epigenetic mechanisms (mainly DNA methylation, histone acetylation/deacetylation, and noncoding microRNAs) may modify gene expression in the absence of an altered DNA sequence, in response to different lithogenic environmental stimuli, such as diet, lifestyle, pollutants, also occurring in utero before birth. In this review, we will comment on various steps of the pathogenesis of cholesterol gallstones and interaction between environmental and genetic factors. The epigenomic approach may offer new options for therapy of gallstones and better possibilities for primary prevention in subjects at risk.

Original languageEnglish (US)
Article number298421
JournalCholesterol
Volume2013
DOIs
StatePublished - May 13 2013
Externally publishedYes

Fingerprint

Gallstones
Epigenomics
Cholesterol
Insulin Resistance
Insulin
Acetylation
DNA sequences
Biosynthesis
Intestinal Absorption
Hyperinsulinism
DNA Methylation
Primary Prevention
Nutrition
Medical problems
Dyslipidemias
Bile Acids and Salts
MicroRNAs
Metabolism
Gene expression
Histones

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Hematology
  • Organic Chemistry

Cite this

Current views on genetics and epigenetics of cholesterol gallstone disease. / Di Ciaula, Agostino; Wang, David Q.H.; Bonfrate, Leonilde; Portincasa, Piero.

In: Cholesterol, Vol. 2013, 298421, 13.05.2013.

Research output: Contribution to journalReview article

Di Ciaula, Agostino ; Wang, David Q.H. ; Bonfrate, Leonilde ; Portincasa, Piero. / Current views on genetics and epigenetics of cholesterol gallstone disease. In: Cholesterol. 2013 ; Vol. 2013.
@article{de516124812f48aabc47f970df5fd911,
title = "Current views on genetics and epigenetics of cholesterol gallstone disease",
abstract = "Cholesterol gallstone disease, one of the commonest digestive diseases in western countries, is induced by an imbalance in cholesterol metabolism, which involves intestinal absorption, hepatic biosynthesis, and biliary output of cholesterol, and its conversion to bile acids. Several components of the metabolic syndrome (e.g., obesity, type 2 diabetes, dyslipidemia, and hyperinsulinemia) are also well-known risk factors for gallstones, suggesting the existence of interplay between common pathophysiological pathways influenced by insulin resistance, genetic, epigenetic, and environmental factors. Cholesterol gallstones may be enhanced, at least in part, by the abnormal expression of a set of the genes that affect cholesterol homeostasis and lead to insulin resistance. Additionally, epigenetic mechanisms (mainly DNA methylation, histone acetylation/deacetylation, and noncoding microRNAs) may modify gene expression in the absence of an altered DNA sequence, in response to different lithogenic environmental stimuli, such as diet, lifestyle, pollutants, also occurring in utero before birth. In this review, we will comment on various steps of the pathogenesis of cholesterol gallstones and interaction between environmental and genetic factors. The epigenomic approach may offer new options for therapy of gallstones and better possibilities for primary prevention in subjects at risk.",
author = "{Di Ciaula}, Agostino and Wang, {David Q.H.} and Leonilde Bonfrate and Piero Portincasa",
year = "2013",
month = "5",
day = "13",
doi = "10.1155/2013/298421",
language = "English (US)",
volume = "2013",
journal = "Cholesterol",
issn = "2090-1283",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Current views on genetics and epigenetics of cholesterol gallstone disease

AU - Di Ciaula, Agostino

AU - Wang, David Q.H.

AU - Bonfrate, Leonilde

AU - Portincasa, Piero

PY - 2013/5/13

Y1 - 2013/5/13

N2 - Cholesterol gallstone disease, one of the commonest digestive diseases in western countries, is induced by an imbalance in cholesterol metabolism, which involves intestinal absorption, hepatic biosynthesis, and biliary output of cholesterol, and its conversion to bile acids. Several components of the metabolic syndrome (e.g., obesity, type 2 diabetes, dyslipidemia, and hyperinsulinemia) are also well-known risk factors for gallstones, suggesting the existence of interplay between common pathophysiological pathways influenced by insulin resistance, genetic, epigenetic, and environmental factors. Cholesterol gallstones may be enhanced, at least in part, by the abnormal expression of a set of the genes that affect cholesterol homeostasis and lead to insulin resistance. Additionally, epigenetic mechanisms (mainly DNA methylation, histone acetylation/deacetylation, and noncoding microRNAs) may modify gene expression in the absence of an altered DNA sequence, in response to different lithogenic environmental stimuli, such as diet, lifestyle, pollutants, also occurring in utero before birth. In this review, we will comment on various steps of the pathogenesis of cholesterol gallstones and interaction between environmental and genetic factors. The epigenomic approach may offer new options for therapy of gallstones and better possibilities for primary prevention in subjects at risk.

AB - Cholesterol gallstone disease, one of the commonest digestive diseases in western countries, is induced by an imbalance in cholesterol metabolism, which involves intestinal absorption, hepatic biosynthesis, and biliary output of cholesterol, and its conversion to bile acids. Several components of the metabolic syndrome (e.g., obesity, type 2 diabetes, dyslipidemia, and hyperinsulinemia) are also well-known risk factors for gallstones, suggesting the existence of interplay between common pathophysiological pathways influenced by insulin resistance, genetic, epigenetic, and environmental factors. Cholesterol gallstones may be enhanced, at least in part, by the abnormal expression of a set of the genes that affect cholesterol homeostasis and lead to insulin resistance. Additionally, epigenetic mechanisms (mainly DNA methylation, histone acetylation/deacetylation, and noncoding microRNAs) may modify gene expression in the absence of an altered DNA sequence, in response to different lithogenic environmental stimuli, such as diet, lifestyle, pollutants, also occurring in utero before birth. In this review, we will comment on various steps of the pathogenesis of cholesterol gallstones and interaction between environmental and genetic factors. The epigenomic approach may offer new options for therapy of gallstones and better possibilities for primary prevention in subjects at risk.

UR - http://www.scopus.com/inward/record.url?scp=84877289258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877289258&partnerID=8YFLogxK

U2 - 10.1155/2013/298421

DO - 10.1155/2013/298421

M3 - Review article

C2 - 23691293

AN - SCOPUS:84877289258

VL - 2013

JO - Cholesterol

JF - Cholesterol

SN - 2090-1283

M1 - 298421

ER -